US 10,010,530 B2
A CARBOXAMIDE DERIVATIVE AND ITS DIASTEREOMERS IN STABLE CRYSTALLINE FORM
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in

General

US 10,010,530 B2
A CARBOXAMIDE DERIVATIVE AND ITS DIASTEREOMERS IN STABLE CRYSTALLINE FORM
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Kamal Saeed
Art Unit:
1626 Organic Chemistry
Agent:
Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
Inventors:
Olli T¿RM¿KANGAS; Terhi HEIKKINEN
Assignee:
ORION CORPORATION
Priority:
01/28/16
Filed:
07/28/17
Granted:
07/03/18
Expiration:
01/28/36
Abstract
The present disclosure relates to solid crystalline forms of N—((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide (I) and the diastereomers thereof, and to methods for preparing such crystalline forms. Compound (I) and the diastereomers thereof are potent androgen receptor (AR) modulators useful as a medicament.
Cooperative Patent Classification (CPC)
C07C07D231/14C07DA61K31/4155A61P35/00A61K

Analytics

Cases

Patent Assignments

Citations